TG101209 50mg

TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells.

Price Not Available 50mg TG101209 50mg Supplier Page

Trivial name	TG101209 50mg
Catalog Number	A11180-50
Alternative Name(s)	N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide
Molecular Formula	C26H35N7O2S
CAS#	936091-14-4
SMILES	CN1CCN(CC1)C2=CC=C(C=C2)NC3N=C(NC4=CC(=CC=C4)S(=O)(=O)NC(C)(C)C)C(C)=CN=3
Size	50mg
Supplier Page	http://www.adooq.com/tg101209.html